San Francisco, CA – July 17th, 2024 – BIOMAKERS, a Precision Medicine & Biotech Company that supports data-driven Drug Development globally, and TOPAZIUM, an AI-driven healthtech company specializing in drug discovery and human wellbeing, have announced the results of their innovative collaborative project. This partnership showcases the power of AI systems in leveraging real-world DNA…
The magazine Emprendedores has organised a second meeting to discuss the impact of artificial intelligence (AI) on business. The aim was for the meeting to be practical for all attendees, featuring use cases from entrepreneurs in various sectors of the economy who have been leveraging AI for years to make their organizations and solutions more…
On June 11, Topazium presented at Madrid Innovation Lab (MIL; https://milmadrid.es/) its project HealthGuard, winner of the challenge “Mechanisms for Predicting and Controlling Chronic Diseases” at the 2023 AI and Advanced Technologies Awards. After a few words of welcome, Patricia Sarasola, Head of the Innovation Department of the Madrid City Council, emphasized the accessibility of…
Two machine learning frameworks developed in Topazium, GFPrint™ and PredLung™, have been used to extract important information from cancer patients, in particular from lung cancer patients, that may serve to design better therapies, generate virtual biomarker signatures and predict patient outcomes. Three case studies are presented, focused on i) the discovery of potential novel targets…
Madrid, February 21, 2024. Topazium, a company specializing in the application of artificial intelligence in the field of biomedicine, has been awarded the 2023 Artificial Intelligence and Advanced Technologies Award by the Madrid City Council for HealthGuard™, a machine learning framework designed and developed by the company that utilizes the most advanced AI technologies to…